№ lp_1_2_25498
File format: docx
Character count: 2173
File size: 30 KB
Note:
Year
Document Type:
Letter
Target Audience:
Primary Care Prescriber
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
Not specified
Region / city:
Not specified
Topic:
Medical Assessment, Bed and Mattress Management
Document Type:
Assessment Form
Organization / Institution:
SWEP
Author:
SWEP Clinical Advisors
Target Audience:
Healthcare professionals, caregivers
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Country:
Australia
Type of document:
Application form
Issuing authority:
Therapeutic Goods Administration (TGA)
Intended audience:
Medical practitioners
Purpose:
Application to become an authorised prescriber of unapproved medicines or medical devices
Regulatory reference:
Therapeutic Goods Regulations 1990, Regulation 12B(1B)
Required attachments:
Ethics committee or specialist college approval/declaration (if applicable)
Information collected:
Personal details of medical practitioner, patient consent, product information, prescribing details
Submission method:
Email or fax to TGA
Year:
Not specified
Region / City:
Not specified
Topic:
Medicine Prescriber Category Change
Document Type:
Form
Institution:
Ministry of Health (MOH)
Author:
Not specified
Target Audience:
Healthcare professionals involved in prescribing medicines
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Contextual Description:
Form for proposing changes to the prescriber category of medicines in the Ministry of Health Medicines Formulary, including necessary information about the medicine, dosage, and rationale for the change.
Year:
1993
Region / City:
Massachusetts
Subject:
Nursing Practice
Document Type:
Advisory Ruling
Authority:
Massachusetts Board of Registration in Nursing
Target Audience:
Registered Nurses, Licensed Practical Nurses
Period of Validity:
Ongoing
Approval Date:
September 22, 1993
Revision Dates:
July 10, 2002; December 9, 2009; October 8, 2014; April 11, 2018
Year:
2023
Region / City:
Humber & North Yorkshire
Topic:
Healthcare, Community Pharmacy, Data Privacy
Document Type:
Programme Description
Organization / Institution:
NHS England, Humber & North Yorkshire Integrated Care Board
Author:
NHS England
Target Audience:
Healthcare professionals, community pharmacies
Period of Implementation:
April 2023 – April 2025
Approval Date:
Not specified
Modification Date:
Not specified
Year:
1989
Region / City:
Australia
Topic:
Therapeutic Goods
Document Type:
Application Form
Organization / Institution:
HREC
Author:
Unknown
Target Audience:
Medical practitioners, HREC members
Effective Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / city:
Australia
Topic:
Psychedelic-assisted therapy, psilocybin
Document type:
Application form
Organization:
Therapeutic Goods Administration (TGA), National Institute of Integrative Medicine (NIIM)
Author:
Not specified
Target audience:
Registered psychiatrists seeking approval to prescribe psilocybin
Validity period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2026
Region / City:
Australia
Subject:
Authorised Prescriber Approval Renewal and Amendments
Document Type:
Application Checklist / Form
Organization:
NIIM HREC
Author:
Not specified
Target Audience:
Healthcare professionals seeking Authorised Prescriber approval
Effective Period:
Ongoing until next renewal
Date of Issue:
2026
Attachments Required:
Renewal and Amendment Form, Original NIIM HREC Approval Letter, Amendment Letters (if applicable), Evidence of Continuing Professional Education, Product Information, Proof of Payment
Year:
2023
Region / Country:
Australia
Subject:
Nursing and midwifery practice regulation
Document type:
Consultation Regulation Impact Statement (C-RIS)
Issuing body:
Nursing and Midwifery Board of Australia (NMBA)
Authors / Contributors:
Registered Nurse Prescribing Working Group, NMBA
Target audience:
Healthcare professionals, policymakers, stakeholders in nursing and midwifery
Consultation period:
16 June 2023 – 28 July 2023
Related documents:
NMBA Registration Standards, ANMAC Endorsed Midwife Accreditation Standards, Health Workforce Australia HPPP Project Report, NPS Prescribing Competency Framework
Purpose:
Evaluate regulatory impacts of proposed nurse prescribing registration standard
Submission method:
Email to [email protected]
Note:
in Word format
Decision-making process:
Feedback reviewed to develop Decision RIS for Ministerial approval
Summary:
Evaluative government source analyzing options for implementing designated registered nurse prescribing and consulting stakeholders on regulatory impacts.
Organisation:
Melksham and Bradford on Avon Primary Care Network (M&BoA PCN)
Job title:
Social Prescriber Link Worker (SPLW)
Line manager:
Social Prescribing Development Lead
Accountable to:
PCN Network Manager
Hours per week:
Flexible up to full-time (37.5 hours)
Salary:
£15.20 – £15.32 per hour
Location:
Bradford on Avon and Melksham, United Kingdom
Population covered:
Approximately 48,000 patients
Participating practices:
Bradford on Avon & Melksham Health Partnership; Giffords Surgery; Spa Medical Centre
Team structure:
Wellbeing Team including Health Coaches, Social Prescribing Link Workers and Care Coordinators
Target population:
Adults aged 18 years and over, including older people
Employment sector:
Primary Care / General Practice
Service focus:
Social prescribing and community-based wellbeing support
Legislative framework:
Health and Safety at Work Act 1974; Environmental Protection Act 1990; Environment Act 1995; Fire Precautions (Workplace) Regulations 1999; Coronavirus Act 2020
Core principles:
Equality, Diversity and Inclusion; Confidentiality; Quality and Continuous Improvement; Safety, Health, Environment and Fire (SHEF)
Referral system:
GP clinical systems using national SNOMED codes
Induction requirement:
Full induction within M&BoA PCN and member practices
Training requirement:
Mandatory training as directed by Host Practice
Year:
2026
Country:
Australia
Document type:
Fact sheet
Regulatory body:
Nursing and Midwifery Board of Australia (NMBA)
Subject:
Endorsement for scheduled medicines for registered nurses
Target audience:
Registered nurses in Australia seeking endorsement
Effective date:
30 September 2025
Requirements:
NMBA-approved postgraduate education, 5,000 hours of clinical experience, clinical mentorship
Scope:
Administration, possession, prescribing, supply, and use of Schedule 2, 3, 4, and 8 medicines under prescribing agreements
Related legislation:
Health Practitioner Regulation National Law, state and territory medicines and poisons legislation, Therapeutic Goods Administration regulations
Year:
2017
Region / City:
United States
Subject:
Workforce Development, Monitoring
Document Type:
Guideline
Agency/Organization:
U.S. Department of Education, U.S. Department of Labor, U.S. Department of Health and Human Services
Author:
Multiple Federal Agencies
Target Audience:
State and local workforce development boards, federal partners
Period of Validity:
2017–ongoing
Approval Date:
November 9, 2017
Date of Amendments:
Not specified
Year:
2026
Version:
NENC v2.0
Date published:
22 January 2026
Planned review date:
October 2027
Region:
North East and North Cumbria
Healthcare system:
NHS
Clinical area:
Neurology
Condition:
Amyotrophic lateral sclerosis
Medicine:
Riluzole
Document type:
Shared care protocol
Indication:
Extension of survival or time to mechanical ventilation in ALS
Target population:
Adults
Intended audience:
NHS healthcare professionals
Initiating authority:
Neurological specialist services
Regulatory reference:
NICE Technology Appraisal TA20
Prescribing setting:
Secondary to primary care transfer
Monitoring requirements:
Liver function tests, full blood count, urea and electrolytes
Route of administration:
Oral or enteral
Licensing status:
Licensed for ALS only
Year:
2026
Region / City:
United States
Topic:
Healthcare, Medicare, Accountable Care Organizations
Document Type:
Instruction Manual
Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
CMS
Target Audience:
Accountable Care Organizations (ACOs), Healthcare Administrators, CMS Staff
Effective Period:
Ongoing, as of January 2026
Approval Date:
January 2026
Revision History Date:
January 2026
Version:
1.0.4
Note:
Region / City
Topic:
Software Installation
Document Type:
Revision History
Organization / Institution:
IVI Foundation
Target Audience:
Developers, System Administrators
Note:
Year
Organization / Institution:
Community Action Program Legal Services, Inc. (CAPLAW)
Year:
2024
Region / City:
North East London
Theme:
Shared care arrangements, prescribing practices
Document Type:
Memorandum of Understanding
Organization / Institution:
North East London Pharmacy and Medicines Optimisation Team
Author:
North East London Pharmacy and Medicines Optimisation Team
Target Audience:
General practitioners, private care providers, patients
Period of Effect:
12/03/2024 - 26/03/2027
Approval Date:
12/03/2024
Date of Ratification:
26/03/2024
Review Date:
26/03/2027
Note:
Year
Subject:
Shared leave request
Document Type:
Form
Organization / Institution:
University of Washington
Target Audience:
Employees of the University of Washington